Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06375460 · ClinicalTrials.gov registry record · NA

Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

A NA study, sponsored by University of Pittsburgh.

Not yet
Registry status
NA
Development phase
100
Enrollment target

NCT06375460: Clinical Trial NA study, sponsored by University of Pittsburgh.

NCT06375460 is a NA study that has not yet begun recruiting, run by University of Pittsburgh. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06375460, a NA study, has not yet begun recruiting, sponsored by University of Pittsburgh.

NOT YET RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic control among adolescents and young adults with T2D. Glycemic control will be monitored using Continuous Glucose Monitors (CGM), and health behavior data will be collected via a Fitbit activity tracker and a research app (Healthmine). Participants will be prompted to view and reflect on glycemic trends and health behavior data (Fitbit data, logging of diet and medication adherence) during the 90-day micro-randomized trial period, then observed for ongoing use of the Healthmine app and engagement with CGM in the following 90-day observation period.

Primary Outcome

measured using continuous glucose monitor

Interventions

  • BEHAVIORAL Focused App Prompt
  • BEHAVIORAL No App Prompt
  • BEHAVIORAL Outreach for Missing Data

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-07
Est. Completion 2029-08
Phase NA
University of Pittsburgh

1,238 total trials

What is known before NCT06375460 opens enrollment

NCT06375460 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which Focused App Prompt is the first listed.

NCT06375460 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06375460 about?

NCT06375460 is a clinical study titled "Real-time Engagement for Learning to Effectively Control Type 2 Diabetes". This is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic control among adolescent...

What is the current status of trial NCT06375460?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2029-08.

What interventions are being tested in trial NCT06375460?

The interventions under investigation include: Focused App Prompt (BEHAVIORAL), No App Prompt (BEHAVIORAL), Outreach for Missing Data (BEHAVIORAL).

Who is sponsoring clinical trial NCT06375460?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06375460's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06375460, the US trial registry maintained by the National Library of Medicine. NCT06375460 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.